Catalog No.
DGX03201
Expression system
Mammalian Cells
Species reactivity
General
Host species
Chimeric
Isotype
IgG1-kappa
Clonality
Monoclonal
Target
Staphylococcus Epidermidis Lipoteichoic Acid
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
BSYX-A110, PMAB, CAS: 595566-61-3
Clone ID
Pagibaximab
Anti-lipoteichoic acid monoclonal antibody (pagibaximab) studies for the prevention of staphylococcal bloodstream infections in preterm infants, PMID: 25736524
A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis, PMID: 21788224
Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates, PMID: 19380597
Safety and pharmacokinetics of a chimerized anti-lipoteichoic acid monoclonal antibody in healthy adults, PMID: 19268719
Antibody-based therapeutics to watch in 2011, PMID: 21051951
Antibody for the prevention of neonatal noscocomial staphylococcal infection: a review of the literature, PMID: 17939955
Recent advances in prevention of sepsis in the premature neonates in NICU, PMID: 21251768
Integration of Ontogeny Into a Physiologically Based Pharmacokinetic Model for Monoclonal Antibodies in Premature Infants, PMID: 31729044
Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants, PMID: 19370635
A rapid opsonic assay for measuring killing of bioluminescent Staphylococcus epidermidis, PMID: 19108622
For research use only. Not for human or drug use.
